{"id":"W2934146457","doi":"10.1177/1203475419840629","title":"Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma","year":2019,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Medicine; Mycosis fungoides; Alemtuzumab; CD52; Lymphomatoid papulosis; Nivolumab; CD30; Lymphoma; Monoclonal antibody therapy; Oncology; Bexarotene; Monoclonal antibody; Immunology; Pembrolizumab; Cutaneous T-cell lymphoma; Dermatology; Immunotherapy; Antibody; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001225338,0.0007360875,0.00554073,0.001297708,0.0001995566,0.00006536008,0.0001778772,0.0004177705,0.00009633735],"category_scores_gemma":[0.002151687,0.0004852858,0.0008672996,0.0003640952,0.0003818303,0.00008372482,0.00007424491,0.0005740158,0.000005883677],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002034235,"about_ca_system_score_gemma":0.001486513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001825587,"about_ca_topic_score_gemma":0.000002896215,"domain_scores_codex":[0.9955881,0.0002442672,0.002055397,0.0005205618,0.0009170426,0.0006745828],"domain_scores_gemma":[0.9894328,0.007483183,0.001506037,0.0003556684,0.0007280883,0.000494205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005045577,0.0001528529,0.0002117502,0.04148371,0.000826292,0.006500902,0.0007432369,3.065799e-7,0.00003007344,0.00001606728,0.008487627,0.9410426],"study_design_scores_gemma":[0.001010064,0.001081259,8.681378e-7,0.02122619,0.00203254,0.2599311,0.0007728058,0.00004319364,0.000002523252,0.00007284181,0.7135022,0.0003243718],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002548396,0.9937763,0.00006583475,0.0007804419,0.0005860144,0.001170456,0.00001903164,0.00002384696,0.00102969],"genre_scores_gemma":[0.0006991885,0.9942745,0.0002939408,0.0004214423,0.00133298,0.00001921666,0.00003616643,0.0001646469,0.002757908],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9407182,"threshold_uncertainty_score":0.9997599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1304439562623827,"score_gpt":0.3945113606673101,"score_spread":0.2640674044049275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}